glycocalyx loss
play

Glycocalyx Loss Podocyte and Kidney Injury Induces Albuminuria Nat Rev Nephrol 2015;11:667-676 Atherosclerotic Lesions Develop After Glycocalyx Loss Nat Rev Nephrol 2015;11:667-676 Mechanism of Glycocalyx Degradation Nat Rev Nephrol

0 downloads 3 Views 383 KB Size Report
  1. Glycocalyx Loss— Podocyte and Kidney Injury Induces Albuminuria Nat Rev Nephrol 2015;11:667-676

  2. Atherosclerotic Lesions Develop After Glycocalyx Loss Nat Rev Nephrol 2015;11:667-676

  3. Mechanism of Glycocalyx Degradation Nat Rev Nephrol 2015;11:667-676

  4. Glycocalyx Thickness is Lower in Children with Type 1 Diabetes J Pediatr 2014;164:584-589

  5. So what is albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction; it symbolizes the kidney’s way of translating the existence of vascular damage.

  6. Prevalence of Albuminuria in the General Population Macroalbuminuria Microalbuminuria >300 mg/24h 30-300 mg/24h 0.7% 7.2% High-Normal Albuminuria 11-29 mg/24h 16.6% Low-Normal Albuminuria N = 40,856 0-10mg/24h 75% J Int Med 2001;249:519-526

  7. The Significance of Albuminuria • Results from injury to systemic and glomerular circulation (loss of glycocalyx) • When increased, associated with progressive decline in renal function • Predicts new onset diabetes risk • When increased, associated with greater risk of cardiovascular, cerebrovascular, and peripheral vascular disease N Engl J Med 2000;342:145-153; Am J Kidney Dis 2000;36:646-661; Am J Kidney Dis 2000;35(4suppl1):S97-S105

  8. Albuminuria Predicts Chronic Kidney Disease in the Non-Diabetes General Population 70 Incidence of Stage 3 CKD (%) 58 60 50 40 22 30 13 20 9 10 0 0 - 14 30 - 300 15 – 29 >300 Albuminuria (mg/day) Stage 3 CKD = creatinine clearance < 60 mL/min Kidney Int 2004;66(suppl 92):1-4

  9. Albuminuria Predicts New Onset Diabetes Risk in General Population 14 New Onset Diabetes (%) 11.8 12 10 7.9 8 6 4.3 4 2.2 2 0 0 - 14 15 – 29 30 - 300 >300 Albuminuria (mg/24h) Diabetes Care 2005;28:2525-2530

  10. Albuminuria Predicts Cardiovascular Death in General Population 35 CV death (% per 1000 patients) 29.1 30 25 20 15 11.2 10 4.5 3.5 5 0 0 - 14 30 - 300 15 – 29 >300 Albuminuria (mg/24h) Circulation 2002;106:1777-1782

  11. Increased All-Cause Morality when the Albumin Creatinine Ratio is > 5 ↓ Kidney Int 2011;79:1341-1352

  12. eGFR and UACR: CVD, Stroke, and CHF Risks ↓ Hyperfiltration ↓ HR: 1.0 HR: 1.0 UACR eGFR 5 mg/g 95 mL/min creatinine ↓ ↓ Lancet Diabetes Endocrinol 2015;3:514-525

Recommend Documents


introducing
INTRODUCING Connecting Weight Loss

INTRODUCING Connecting Weight Loss Patients Directly to your Weight Loss

prior and loss robustness for varoius loss functions
Prior and loss robustness for varoius

Introduction Symmetric loss function Asymmetric loss function ABL Remarks

using loss data to win over clients
Using Loss Data to Win Over Clients

Using Loss Data to Win Over Clients Webinar: June 29 th @ 11am EDT How can you

water loss
Water Loss Water Research Foundation

Water Loss Water Research Foundation How to use the Free Water Loss Audit

loss reserving and the law what every actuary needs to
Loss Reserving And The Law: What Every

Loss Reserving And The Law: What Every Actuary Needs To Know CAS Casualty

water loss
Water Loss May 14, 2020 Water Loss

Water Loss May 14, 2020 Water Loss Regulation Overview Senate Bill 555

presentation of 2017 loss factors determined under loss
Presentation of 2017 Loss Factors

Presentation of 2017 Loss Factors Determined Under Loss Factor Rule John

from icing loss to production loss
From icing loss to production loss - a

From icing loss to production loss - a comprehensive comparison of todays

booster fast loss monitoring
Booster Fast Loss Monitoring PIP

Booster Fast Loss Monitoring PIP Booster Workshop R.J. Tesarek 11/23/15 1

differentiated services delay and loss vs loss rate
Differentiated Services Delay-and-Loss

Differentiated Services Delay-and-Loss vs. Loss-Rate-Adaptive Service Classes

submit
SUBMIT Cas ase P e Presen entat

SUBMIT Cas ase P e Presen entat ation COVID-19 Kurt DeVine, MD and

make it count
Make it count Technical considerations

Make it count Technical considerations and initial findings for accurate

systemic lupus erythematosus presentjng as acute adrenal
Systemic Lupus Erythematosus Presentjng

[Downloaded free from http://www.amhsr.org] Case Report Systemic Lupus

a 12 year old with liver disease and pulmonary
A 12 Year Old with Liver Disease and

A 12 Year Old with Liver Disease and Pulmonary Hypertension Russel Hirsch,

improving the biophysical activity of dysfunctional lung
Improving the Biophysical Activity of

Improving the Biophysical Activity of Dysfunctional Lung Surfactant Vanessa

intercept 1q16 earnings presentation
Intercept 1Q16 Earnings Presentation

Intercept 1Q16 Earnings Presentation May 5 th , 2016 Safe Harbor Statement

management of management of hypertension hypertension
Management of Management of

Management of Management of Hypertension Hypertension M Misra MD MRCP (UK)

dine amp learn roundtable ckd what to expect
Dine & Learn Roundtable CKD What

Dine & Learn Roundtable CKD What to Expect Dr. Caroline Stigant April 30,

chronic kidney disease a team based quality improvement
Chronic Kidney Disease A Team-Based

Chronic Kidney Disease A Team-Based Quality Improvement Project Implementing

decrements in gfr largely correlates to the
decrements in GFR largely correlates

is a physiological property determine function of all single nephrons taken

optimizing renal function pre and post resection of
Optimizing Renal Function Pre- and

Optimizing Renal Function Pre- and Post-Resection of Kidney Cancer : Important

glomerulonephritis notes
Glomerulonephritis notes ! Neil Turner

24/10/2013' Glomerulonephritis 1 Neil Turner Glomerulonephritis